These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1704640)

  • 41. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of chronic hepatitis due to hepatitis B virus.
    Sherlock S; Thomas HC
    Lancet; 1985 Dec; 2(8468):1343-6. PubMed ID: 2866396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
    Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B infection in pediatric dialysis and transplant patients: significance of e antigen.
    Ettenger RB; Tong MJ; Landing BH; Mosley J; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Jordan SC; Wright H; Fine RN
    J Pediatr; 1980 Oct; 97(4):550-3. PubMed ID: 6999141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.
    Bonino F; Rosina F; Rizzetto M; Rizzi R; Chiaberge E; Tardanico R; Callea F; Verme G
    Gastroenterology; 1986 May; 90(5 Pt 1):1268-73. PubMed ID: 3956945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.
    Hoofnagle JH; Dusheiko GM; Seeff LB; Jones EA; Waggoner JG; Bales ZB
    Ann Intern Med; 1981 Jun; 94(6):744-8. PubMed ID: 7235415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
    Weller IV; Bassendine MF; Craxi A; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
    Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evaluation of clinical effectiveness of colchicine in the treatment of chronic active hepatitis with transformation to liver cirrhosis].
    Simon K; Gładysz A; Zalewska M; Machaj A
    Przegl Epidemiol; 1991; 45(4):331-4. PubMed ID: 1841412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of chronic hepatitis B. Part 2: Effect of glycyrrhizic acid on the course of illness].
    Eisenburg J
    Fortschr Med; 1992 Jul; 110(21):395-8. PubMed ID: 1516877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of HBsAg-positive chronic active hepatitis with corticosteroids and/or azathioprine. A prospective study.
    Manzillo G; Piccinino F; Sagnelli E; Izzo CM; Pasquale G; Maio G; Filippini P; Felaco FM
    Ric Clin Lab; 1983; 13(2):261-8. PubMed ID: 6622929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of the effectiveness of isoprinosine in the treatment of patients with acute viral hepatitis. II. Immunological evaluation].
    Nedoszytko B; Michalska Z; Dubicka M; Gajda A
    Wiad Lek; 1987 Nov; 40(21):1469-74. PubMed ID: 2453975
    [No Abstract]   [Full Text] [Related]  

  • 54. Relevance of HBe/anti-HBe system and DNA polymerase activity in chronic hepatitis-B virus carriers on haemodialysis. A prospective study.
    Marchesini G; Zoli M; Angiolini A; Feliciangeli G; Santoro A; Ferroni P; Zanetti AR
    Nephron; 1981; 29(1-2):44-8. PubMed ID: 7329473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [HBe antigen and B virus DNA in patients with chronic active hepatitis].
    Chaussade S; Thiers V; Boboc B; Housset C; Bréchot C; Degos F
    Gastroenterol Clin Biol; 1986 Nov; 10(11):744-7. PubMed ID: 3803809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy.
    Craxi A; Weller IV; Bassendine MF; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
    Gut; 1983 Feb; 24(2):143-7. PubMed ID: 6852624
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children.
    Lai CL; Lok AS; Lin HJ; Wu PC; Yeoh EK; Yeung CY
    Lancet; 1987 Oct; 2(8564):877-80. PubMed ID: 2889081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical importance of hepatitis B virus DNA detection in serum of children with chronic hepatitis B].
    Wirth S; Möllers U; Schaefer E; Schwarze U; Zabel B
    Klin Padiatr; 1992; 204(3):155-7. PubMed ID: 1614181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Receptors for polymerized human serum albumin and other hepatitis B virus markers during acute hepatitis B--predictive value of the outcome of the disease.
    Mora I; Porres JC; Bartolome FJ; Hernandez Guio C; Gutiez J; Carreño V
    Hepatogastroenterology; 1986 Dec; 33(6):250-4. PubMed ID: 3026941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
    Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
    Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.